Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Cardiac and Peripheral Autonomic Responses to Orthostatic Stress During Transcutaneous Vagus Nerve Stimulation in Healthy Subjects.

Tobaldini E, Toschi-Dias E, Appratto de Souza L, Rabello Casali K, Vicenzi M, Sandrone G, Cogliati C, La Rovere MT, Pinna GD, Montano N.

J Clin Med. 2019 Apr 11;8(4). pii: E496. doi: 10.3390/jcm8040496.

2.

Pulmonary Vascular Function and Aerobic Exercise Capacity at Moderate Altitude.

Faoro V, Deboeck G, Vicenzi M, Gaston AF, Simaga B, Doucende G, Hapkova I, Roca E, Subirats E, Durand F, Naeije R.

Med Sci Sports Exerc. 2017 Oct;49(10):2131-2138. doi: 10.1249/MSS.0000000000001320.

PMID:
28915226
3.

Myocardial deformation in iron overload cardiomyopathy: speckle tracking imaging in a beta-thalassemia major population.

Di Odoardo LAF, Giuditta M, Cassinerio E, Roghi A, Pedrotti P, Vicenzi M, Sciumbata VM, Cappellini MD, Pierini A.

Intern Emerg Med. 2017 Sep;12(6):799-809. doi: 10.1007/s11739-017-1670-4. Epub 2017 Apr 29.

PMID:
28456904
4.

Reveal LINQTM experience out of the electrophysiology lab.

Di Odoardo LAF, Ambrosini F, Giavarini A, Vicenzi M, Venturini F, Lombardi F.

J Cardiovasc Med (Hagerstown). 2017 Jul;18(7):550-552. doi: 10.2459/JCM.0000000000000417. No abstract available.

PMID:
27322402
5.

Response to the letter "Pulmonary artery wedge pressure and exercise oscillatory ventilation in pre-capillary pulmonary hypertension".

Vicenzi M, Deboeck G, Faoro V, Vachiery JL, Naeije R.

Int J Cardiol. 2016 Feb 1;204:12. doi: 10.1016/j.ijcard.2015.11.140. Epub 2015 Nov 23. No abstract available.

PMID:
26655525
6.

At high cardiac output, diesel exhaust exposure increases pulmonary vascular resistance and decreases distensibility of pulmonary resistive vessels.

Wauters A, Vicenzi M, De Becker B, Riga JP, Esmaeilzadeh F, Faoro V, Vachiéry JL, van de Borne P, Argacha JF.

Am J Physiol Heart Circ Physiol. 2015 Dec 15;309(12):H2137-44. doi: 10.1152/ajpheart.00149.2015. Epub 2015 Oct 23.

7.

Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension.

Vicenzi M, Deboeck G, Faoro V, Loison J, Vachiery JL, Naeije R.

Int J Cardiol. 2016 Jan 1;202:736-40. doi: 10.1016/j.ijcard.2015.09.087. Epub 2015 Sep 26.

PMID:
26469553
8.

Pulmonary vascular function and exercise capacity in black sub-Saharan Africans.

Simaga B, Vicenzi M, Faoro V, Caravita S, Di Marco G, Forton K, Deboeck G, Lalande S, Naeije R.

J Appl Physiol (1985). 2015 Sep 1;119(5):502-7. doi: 10.1152/japplphysiol.00466.2015. Epub 2015 Jul 23.

9.

Salmeterol improves fluid clearance from alveolar-capillary membrane in COPD patients: a pilot study.

Di Marco F, Guazzi M, Sferrazza Papa GF, Vicenzi M, Santus P, Busatto P, Piffer F, Blasi F, Centanni S.

Pulm Pharmacol Ther. 2012 Feb;25(1):119-23. doi: 10.1016/j.pupt.2011.12.010. Epub 2012 Jan 6.

PMID:
22245487
10.
11.

Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.

Guazzi M, Vicenzi M, Arena R, Guazzi MD.

Circulation. 2011 Jul 12;124(2):164-74. doi: 10.1161/CIRCULATIONAHA.110.983866. Epub 2011 Jun 27.

PMID:
21709061
12.

Cardiopulmonary exercise testing characteristics in heart failure patients with and without concomitant chronic obstructive pulmonary disease.

Guazzi M, Myers J, Vicenzi M, Bensimhon D, Chase P, Pinkstaff S, Arena R.

Am Heart J. 2010 Nov;160(5):900-5. doi: 10.1016/j.ahj.2010.07.014.

PMID:
21095278
13.
14.

Development of a cardiopulmonary exercise prognostic score for optimizing risk stratification in heart failure: the (P)e(R)i(O)dic (B)reathing during (E)xercise (PROBE) study.

Guazzi M, Boracchi P, Arena R, Myers J, Vicenzi M, Peberdy MA, Bensimhon D, Chase P, Reina G.

J Card Fail. 2010 Oct;16(10):799-805. doi: 10.1016/j.cardfail.2010.04.014. Epub 2010 Jun 20.

PMID:
20932461
15.

[Clinical use of phosphodiesterase-5 inhibitors in cardiopulmonary diseases: from experimental evidence to clinical application].

Guazzi M, Vicenzi M, Samaja M.

G Ital Cardiol (Rome). 2009 Nov-Dec;10(11-12):725-37. Review. Italian.

PMID:
20101899
16.

Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study.

Di Marco F, Guazzi M, Vicenzi M, Santus P, Cazzola M, Pappalettera M, Castellotti P, Centanni S.

Pulm Pharmacol Ther. 2010 Jun;23(3):159-64. doi: 10.1016/j.pupt.2010.01.004. Epub 2010 Jan 22.

PMID:
20096799
17.

Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.

Guazzi M, Dickstein K, Vicenzi M, Arena R.

Circ Heart Fail. 2009 Nov;2(6):549-55. doi: 10.1161/CIRCHEARTFAILURE.109.881326. Epub 2009 Sep 28.

PMID:
19919979
18.

Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients.

Agostoni P, Emdin M, Corrà U, Veglia F, Magrì D, Tedesco CC, Berton E, Passino C, Bertella E, Re F, Mezzani A, Belardinelli R, Colombo C, La Gioia R, Vicenzi M, Giannoni A, Scrutinio D, Giannuzzi P, Tondo C, Di Lenarda A, Sinagra G, Piepoli MF, Guazzi M.

Eur Heart J. 2008 Oct;29(19):2367-72. doi: 10.1093/eurheartj/ehn361. Epub 2008 Aug 5.

PMID:
18682448
19.

Prognostic value of flow-mediated dilatation following myocardial infarction.

Guazzi M, Reina G, Gripari P, Tumminello G, Vicenzi M, Arena R.

Int J Cardiol. 2009 Feb 6;132(1):45-50. doi: 10.1016/j.ijcard.2007.10.036. Epub 2008 Jan 3.

PMID:
18180054
20.

Long-term use of sildenafil in the therapeutic management of heart failure.

Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD.

J Am Coll Cardiol. 2007 Nov 27;50(22):2136-44. Epub 2007 Nov 13.

Supplemental Content

Loading ...
Support Center